EMAIL THIS PAGE TO A FRIEND

Cardiovascular research

Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle via reduced eNOS activity.


PMID 26002231

Abstract

Slit2 is a possible modulator of VEGF-induced angiogenesis, but its effects have not been tested on large animal models. We studied the effect of Slit2 on therapeutic angiogenesis induced by VEGF receptor 2 (VEGFR2) ligands Vammin and VEGF-D(ΔNΔC) in vivo in rabbit skeletal muscles. The Slit2 target genes were also studied by RNA sequencing in endothelial cells. Adenoviral intramuscular gene transfers were performed into New Zealand White rabbit hindlimbs. Confocal and multiphoton microscopes were used for blood vessel imaging. Signaling experiments and gene expression analyses were performed to study mechanisms of Slit2 action. Slit2 decreased VEGFR2-mediated vascular permeability. Slit2 also reduced VEGFR2-mediated increase in blood perfusion and capillary enlargement, whereas sprouting of the capillaries was increased. Slit2 gene transfer alone did not have any effects on vascular functions or morphology. VEGFR2 activation was not affected by Slit2, but eNOS phosphorylation was diminished. The transcriptome profiling showed Slit2 down-regulating angiogenesis-related genes such as Nuclear receptor subfamily 4 group A member 1 (NR4A1) and Stanniocalcin-1 (STC-1) as well as genes related to endothelial cell migration and vascular permeability. Combining Slit2 with VEGFs adjusts VEGFR2-mediated angiogenic effects into a more physiological direction. This possibly allows the use of higher VEGF vector doses to achieve a more widespread vector and VEGF distribution in the target tissues leading to a better therapeutic outcome while reducing excess vascular permeability.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4300356
Anti-KDR (Ab-1175) antibody produced in rabbit, affinity isolated antibody
SAB4300357
Anti-KDR (Ab-1214) antibody produced in rabbit, affinity isolated antibody
SAB4300358
Anti-KDR (Ab-951) antibody produced in rabbit, affinity isolated antibody
SAB2900238
Anti-KDR (AB1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2900239
Anti-KDR (AB2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2101239
Anti-KDR antibody produced in rabbit, affinity isolated antibody
V1014 Anti-Vascular Endothelial Growth Factor Receptor 2 antibody produced in goat, affinity isolated antibody, lyophilized powder
GW21181 Anti-VEGFR-2 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB4300657
Anti-VEGFR2 (Ab-1059) antibody produced in rabbit, affinity isolated antibody
SAB4501645
Anti-VEGFR2 antibody produced in rabbit, affinity isolated antibody
SAB4501642
Anti-VEGFR2, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4501643
Anti-VEGFR2, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4501644
Anti-VEGFR2, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4500965
Anti-VEGFR2, C-Terminal antibody produced in rabbit, affinity isolated antibody
WH0003791M1
Monoclonal Anti-KDR antibody produced in mouse, clone 2A2, purified immunoglobulin, buffered aqueous solution
SAB1404004
Monoclonal Anti-KDR antibody produced in mouse, clone 4A2, purified immunoglobulin, buffered aqueous solution
V9134
Monoclonal Anti-Vascular Endothelial Growth Factor Receptor-2 antibody produced in mouse, clone KDR-1, ascites fluid